Correction: GRB2 promotes brain metastasis in HER2-positive breast cancer by regulating the Ras/MAPK pathway

Key Points

• Brain metastasis is significantly influenced by GRB2 activity, impacting treatment outcomes.
• The Ras/MAPK pathway is a critical mediator in GRB2's modulation of metastasis.
• Analysis of HER2-positive breast cancer cell lines revealed specific interactions involving GRB2.
• Targeting GRB2 may offer new therapeutic strategies for managing advanced breast cancer.